APEX1 and hepatocellular carcinoma: We enhanced the expression of MAP2K6 in sh-APEX1-treated HCC cells and found that overexpression of MAP2K6 could abolish the role of inhibition of APEX1 in attenuating cell vitality, colony formation and proliferation (Figure 6B–6D).